Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from ...

a few days after the Food and Drug Administration lifted a shortage on Novo Nordisk’s Wegovy and Ozempic. The drugmaker will now offer 7.5mg and 10mg doses of Zepbound, which uses the active ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Besides the expiration date, make a note of the first time you use each pre-filled pen or open each vial. Ozempic is good for 56 days once opened, as long as it’s kept in the fridge or at room ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Drug compounders, led by industry trade group Outsourcing Facilities Association, sued the FDA on Monday over its decision to remove Wegovy and diabetes drug Ozempic ... in vials at lower prices.

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug ... its decision to remove Wegovy and diabetes drug Ozempic, which have the same active ingredient, from ...